Discover why Medtronic's growth in robotics, AI, & solid fundamentals make it a Buy ahead of earnings. Read my analysis here.

A Medtronic (NYSE:MDT) official said today on LinkedIn that the company won CE mark for its Crescent RA jugular dual lumen ...

Medtronic (MDT) ended the recent trading session at $92.20, demonstrating a +0.93% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 1.04%.

When Geoff Martha, chairman and CEO of Medtronic, took over the medical device maker’s Restorative Therapies Group in 2015, ...

Medtronic will use the technology to develop PEEK interbody spine fusion devices that enhance implant fixation.

Here are five headlines to know about Medtronic, as reported by Becker's since Jan. 7: 1. Medtronic acquired rights and intellectual property related to Nanovis' Sites Medical's OsteoSync titanium ...

Scientists are now speculating that the first person to live to 150 years may already be among us. But where might this ...

Nanovis announced today that it sold certain nano surface technology assets and certain IP rights to Medtronic.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Medtronic (MDT – Research Report), Biohaven Ltd. (BHVN – ...

Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...